Skip to main content
. 2022 Aug 10;17:65. doi: 10.1186/s13000-022-01247-y

Table 3.

Maintenance Immunosuppression Therapy in de novo and Recurrent NASH

Immunosuppressant (± Mycophenolate) De Novo
NASH
(n = 37)
Recurrent NASH (n = 19) P value
Tacrolimus 21 (56.8%) 14 (73.7%) 0.2559
Cyclosporine 4 (10.8%) 2 (10.5%)  > 0.9999
Everolimus 1 (2.7%) 0 (0%)  > 0.9999
Sirolimus 2 (5.4%) 0 (0%) 0.5435
Mycophenolate only 6 (16.2%) 3 (15.8%)  > 0.9999